← All Sponsors
SPONSOR

Anwaar Saeed

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Pancreatic Adenocarcinoma
NCT06896188 Phase 1
Recruiting

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Pancreatic Adenocarcinoma
United States View Trial →